- Details
- Description
Packaging Size:
120 tablets/box
Strength:
60 mg
Composition:
Apalutamide 60 mg
Treatment:
Non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC), generally used with androgen-deprivation therapy (ADT).
Form:
Tablet
Brand:
Apaluda
Quantity Unit:
Tablet/Box
Manufacturer:
Beacon Pharmaceuticals PLC
Apaluda (Apalutamide) is an oral anti-androgen anticancer medicine manufactured by Beacon Pharmaceuticals PLC. It is an androgen receptor inhibitor used primarily to treat non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC). Apalutamide works by blocking androgen receptor signaling, which helps slow or stop the growth of prostate cancer cells. It is used under specialist medical supervision, typically in combination with androgen-deprivation therapy (ADT).
